Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2010
06/16/2010CN101731694A Pumpkin soybean milk beverage
06/16/2010CN101731507A Method for preparing honey fructose
06/16/2010CN101731506A Health-care food of bee glue and wood frog lecithin capsule
06/16/2010CN101731400A Fat-removal slimming tea and preparation method thereof
06/16/2010CN101731391A Sanqing broadleaf holly leaf
06/16/2010CN101306015B Composition for increasing embryo quality and preventing and curing defect baby from generating
06/16/2010CN101269051B Rumen bypass becholine microcapsule and preparation technique
06/16/2010CN101259118B Application of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalcone as PPAR gamma agonist
06/16/2010CN101032523B Royal jelly acid calcium and preparation process thereof
06/16/2010CN101027074B Total enteral nutritious composition
06/16/2010CN101023767B Bamboo charcoal tea-cube
06/16/2010CN101002625B Beverage for relieving summer heat, and its preparing process
06/16/2010CN101001620B Use of alpha-ketoglutarate and related compounds for lowering plasma lipids
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737264 Oligomeric compounds for the modulation HIF-1α expression
06/15/2010US7737176 Substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them
06/15/2010US7737161 such as 5-amino-N-(5-chloropyridin-2-yl)-3-{[(trans-4-pyrrolidin-1-ylcyclohexyl)carbonyl]amino}furo[3,2-b]pyridine-2-carboxamide, used as activated blood coagulation factor X inhibitors
06/15/2010US7737155 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases
06/15/2010US7737116 Modified and stabilized GDF propeptides and uses thereof
06/15/2010US7736899 Cells and method for producing proteins comprising an unconventional amino acid
06/15/2010US7736885 Method for production of arachidonic acid
06/15/2010US7736678 Method of enhancing blood antioxidant activity ingesting a compound in the form of at least one form selected from amongst juice, powder, granule, tablet and capsule, which contains an effective amount of at least one vegetable selected from the group consisting of broccoli, spinach, parsley, komatsuna (Brassicad rapa L.) and japanese radish leaves, and at least one vegetable selected from amongst lettuce, cabbage and celery
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010CA2493391C Novel thiophene glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
06/15/2010CA2442256C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
06/15/2010CA2441309C Biguanide derivatives
06/15/2010CA2440648C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
06/15/2010CA2419875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
06/15/2010CA2410253C Regulating lipid levels via the zmax1 or hbm gene
06/15/2010CA2402609C Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/15/2010CA2341700C Compositions and methods for treatment of mitochondrial diseases
06/15/2010CA2303820C Metal compounds, mixed or sulphated, as phosphate binders
06/15/2010CA2285939C Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
06/10/2010WO2010065889A2 Cyclobutanemethanamine inhibitors of monomine reuptake
06/10/2010WO2010065883A2 Method of treating an overweight or obese subject
06/10/2010WO2010065881A2 Methods of treating an overweight or obese subject
06/10/2010WO2010065879A2 Methods of treating an overweight or obese subject
06/10/2010WO2010065815A2 Mini-hepcidin peptides and methods of using thereof
06/10/2010WO2010065803A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
06/10/2010WO2010065802A2 Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
06/10/2010WO2010065800A1 Hydrazine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010065799A2 Amine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010065439A1 Variants of fibroblast growth factor 21
06/10/2010WO2010065069A2 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
06/10/2010WO2010065024A1 Topical treatment of cataracts in dogs
06/10/2010WO2010064845A2 The pharmaceutical composition or the functional foods for the treatment or prevention of obesity comprising the extract from myristica fragrans houttuyn
06/10/2010WO2010064714A1 Nutrient composition
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064665A1 Therapeutic agents
06/10/2010WO2010064633A1 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010063663A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063662A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063237A1 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
06/10/2010WO2010063123A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010WO2010025370A3 Preparation of ranolazine
06/10/2010WO2010025251A3 Materials and methods for modulating appetite, weight gain and adhd using varenicline
06/10/2010WO2010011331A3 Compositions and methods related to sirt1 function
06/10/2010WO2010011319A3 Magnetic heating for drug delivery and other applications
06/10/2010WO2009147170A3 Drug combinations comprising a dgat inhibitor and a ppar-agonist
06/10/2010WO2009073186A8 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
06/10/2010WO2009033561A8 Substituted 6-phenylnicotinic acids and the use thereof
06/10/2010US20100146642 Methods and compositions relating to PBK1
06/10/2010US20100144889 Cholesterol control agent
06/10/2010US20100144880 Amino acid inhibitors of plasmin
06/10/2010US20100144874 Use of a PPARalpha Agonist and Metformin for Decreasing the Serum Triglycerides
06/10/2010US20100144868 Novel Neuroprotective Compounds and Uses Thereof
06/10/2010US20100144864 Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
06/10/2010US20100144862 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
06/10/2010US20100144834 Methods for treating hypercholesterolemia
06/10/2010US20100144827 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
06/10/2010US20100144824 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144815 Amino acid composition
06/10/2010US20100144811 Combination
06/10/2010US20100144807 Pharmaceutical composition for modified release
06/10/2010US20100144806 Cyclopropanecarboxylic Acid Compound
06/10/2010US20100144801 Muscarinic receptor antagonists
06/10/2010US20100144791 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
06/10/2010US20100144774 Heterocyclic spiro-compounds
06/10/2010US20100144772 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
06/10/2010US20100144765 5,6-trimethylenepyrimidin-4-one compounds
06/10/2010US20100144764 Pyrimidinedione derivatives and methods of use thereof
06/10/2010US20100144762 Novel sulfonamides as l-cpt1 inhibitors
06/10/2010US20100144756 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/10/2010US20100144755 Novel Compounds
06/10/2010US20100144744 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
06/10/2010US20100144731 Novel Biccyclic Compounds As GATA Modulators
06/10/2010US20100144722 Novel heterocyclic compounds as gata modulators
06/10/2010US20100144721 Inhibitors of c-met and uses thereof
06/10/2010US20100144701 Modulators of CB1 Receptors
06/10/2010US20100144695 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/10/2010US20100144694 1,2-diazetidin-3-one derivatives and drugs containing same
06/10/2010US20100144677 Method for screening agents for the treatment of diabetes
06/10/2010US20100144668 Semi-fluid food product including beta glucane fibres and guar gum, and use thereof as a functional food product
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100144638 Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
06/10/2010US20100144617 Oxyntomodulin Derivatives
06/10/2010US20100144600 Osteoprotegerin variant proteins
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 1298